AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING LUNG CANCERS

The present invention relates to a human AMHRII-binding agent for its use for preventing or treating a lung cancer, and especially a non-small call lung cancer (NSCLC), and even more especially a NSCLC selected in a group comprising epidermoid NSCLC, adenocarcinoma NSCLC, large cells NSCLC and squam...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PROST JEAN-FRANCOIS, LAHMAR MEHDI, DUBREUIL OLIVIER, BARRET JEAN-MARC, DEGOVE STEPHANE, MESURE DIDIER, NICOLAS ANDRE
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a human AMHRII-binding agent for its use for preventing or treating a lung cancer, and especially a non-small call lung cancer (NSCLC), and even more especially a NSCLC selected in a group comprising epidermoid NSCLC, adenocarcinoma NSCLC, large cells NSCLC and squamous cell carcinoma NSCLC and neuroendocrine NSCLC. 本发明涉及人AMHRII结合剂用于预防或治疗肺癌的用途，特别是涉及人AMHRII结合剂用于预防或治疗非小细胞肺癌(NSCLC)的用途，甚至更特别地涉及人AMHRII结合剂用于预防或治疗选自包括以下的组的NSCLC的用途：表皮样NSCLC、腺癌NSCLC、大细胞NSCLC和鳞状细胞癌NSCLC及神经内分泌NSCLC。